Found: 14
Select item for more details and to access through your institution.
Molecular genetic and immunotherapeutic targets in metastatic melanoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dabrafenib plus trametinib in BRAF K601E‐mutant melanoma.
- Published in:
- British Journal of Dermatology, 2019, v. 180, n. 2, p. 421, doi. 10.1111/bjd.17250
- By:
- Publication type:
- Article
Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis".
- Published in:
- Sarcoma, 2021, p. 1, doi. 10.1155/2021/4653987
- By:
- Publication type:
- Article
Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis.
- Published in:
- Sarcoma, 2020, p. 1, doi. 10.1155/2020/1385978
- By:
- Publication type:
- Article
Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.
- Published in:
- Frontiers in Nephrology, 2023, v. 3, p. 1, doi. 10.3389/fneph.2022.1129134
- By:
- Publication type:
- Article
Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.
- Published in:
- Frontiers in Nephrology, 2022, v. 2, p. 1, doi. 10.3389/fneph.2022.1041819
- By:
- Publication type:
- Article
Clinical presentation, treatment modalities and outcome in patients with adrenocortical carcinoma: A single center experience.
- Published in:
- Neoplasma, 2020, v. 67, n. 1, p. 209, doi. 10.4149/neo_2019_190105N17
- By:
- Publication type:
- Article
FINAL DATA FROM THE PHASE 3 ALCANZA STUDY: BRENTUXIMAB VEDOTIN (BV) VS PHYSICIAN'S CHOICE (PC) IN PATIENTS (PTS) WITH CD30‐POSITIVE (CD30+) CUTANEOUS T‐CELL LYMPHOMA (CTCL).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 286, doi. 10.1002/hon.96_2630
- By:
- Publication type:
- Article
FINAL DATA FROM THE PHASE 3 ALCANZA STUDY: BRENTUXIMAB VEDOTIN (BV) VS PHYSICIAN'S CHOICE (PC) IN PATIENTS (PTS) WITH CD30‐POSITIVE (CD30+) CUTANEOUS T‐CELL LYMPHOMA (CTCL).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 286, doi. 10.1002/hon.96_2630
- By:
- Publication type:
- Article
BRENTUXIMAB VEDOTIN VS PHYSICIAN'S CHOICE IN CTCL PATIENTS FROM THE PHASE 3 ALCANZA STUDY: ANALYSIS OF OUTCOMES BY CD30 EXPRESSION.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 77, doi. 10.1002/hon.2437_65
- By:
- Publication type:
- Article
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Skin Implant Metastasis After Percutaneous Radio-Frequency Therapy of Liver Metastasis of a Colorectal Carcinoma.
- Published in:
- American Surgeon, 2003, v. 69, n. 9, p. 763, doi. 10.1177/000313480306900906
- By:
- Publication type:
- Article
Defining pseudoprogression in glioblastoma multiforme.
- Published in:
- European Journal of Neurology, 2013, v. 20, n. 10, p. 1335, doi. 10.1111/ene.12192
- By:
- Publication type:
- Article
Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article